CN107889997A - 一种益生菌冻干粉固体饮料 - Google Patents
一种益生菌冻干粉固体饮料 Download PDFInfo
- Publication number
- CN107889997A CN107889997A CN201711206121.1A CN201711206121A CN107889997A CN 107889997 A CN107889997 A CN 107889997A CN 201711206121 A CN201711206121 A CN 201711206121A CN 107889997 A CN107889997 A CN 107889997A
- Authority
- CN
- China
- Prior art keywords
- probioctics
- freeze
- solid beverage
- dry powder
- lactic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 38
- 235000013361 beverage Nutrition 0.000 title claims abstract description 20
- 239000007787 solid Substances 0.000 title claims abstract description 20
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 40
- 241000894006 Bacteria Species 0.000 claims abstract description 23
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 20
- 239000004310 lactic acid Substances 0.000 claims abstract description 20
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 17
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 17
- 238000002360 preparation method Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 12
- 210000004369 blood Anatomy 0.000 abstract description 12
- 210000000936 intestine Anatomy 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 230000006870 function Effects 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 3
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 2
- 208000018556 stomach disease Diseases 0.000 abstract description 2
- 206010010774 Constipation Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 240000001929 Lactobacillus brevis Species 0.000 description 1
- 241000186605 Lactobacillus paracasei Species 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- 241000186866 Lactobacillus thermophilus Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- LYPFDBRUNKHDGX-SOGSVHMOSA-N N1C2=CC=C1\C(=C1\C=CC(=N1)\C(=C1\C=C/C(/N1)=C(/C1=N/C(/CC1)=C2/C1=CC(O)=CC=C1)C1=CC(O)=CC=C1)\C1=CC(O)=CC=C1)C1=CC(O)=CC=C1 Chemical compound N1C2=CC=C1\C(=C1\C=CC(=N1)\C(=C1\C=C/C(/N1)=C(/C1=N/C(/CC1)=C2/C1=CC(O)=CC=C1)C1=CC(O)=CC=C1)\C1=CC(O)=CC=C1)C1=CC(O)=CC=C1 LYPFDBRUNKHDGX-SOGSVHMOSA-N 0.000 description 1
- FLDFNEBHEXLZRX-DLQNOBSRSA-N Nystose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FLDFNEBHEXLZRX-DLQNOBSRSA-N 0.000 description 1
- 206010039984 Senile osteoporosis Diseases 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 208000035239 Synesthesia Diseases 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 1
- 229940009289 bifidobacterium lactis Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- FLDFNEBHEXLZRX-UHFFFAOYSA-N nystose Natural products OC1C(O)C(CO)OC1(CO)OCC1(OCC2(OC3C(C(O)C(O)C(CO)O3)O)C(C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 FLDFNEBHEXLZRX-UHFFFAOYSA-N 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960002197 temoporfin Drugs 0.000 description 1
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/519—Breve
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及一种益生菌冻干粉固体饮料,属于保健饮品技术领域。本发明的技术方案是:一种益生菌冻干粉固体饮料,含有低聚异麦芽糖、低聚果糖、低聚半乳糖、乳酸菌粉。经常服用本发明固体饮料,具有调节血脂,降低血液粘稠度等保护心脑血管的作用;还具缓解或防治肠胃功能紊乱等类似于亚健康的现代病,满足现代人的生活需求。
Description
【技术领域】
本发明涉及一种益生菌冻干粉固体饮料,属于保健饮品技术领域。
【背景技术】
随着社会的进步,人们生活水平的提高,以及现代人生活节奏的加快,生活压力和工作压力等问题,人们经常会出现腰酸背痛等骨质疏松症状,以及牙痛,高血压、高血脂,肠胃功能紊乱等类似于亚健康的现代病。
长期的亚健康状态,以及高血压、高血脂、肠胃功能紊乱,会引发实质性变化,如人体器官功能的退化,心血管疾病等各种不应有的病症会找上门。如果疾病找上门来的时候,恐怕是是为时已晚,如果能在日常生活中为人们提供一种保健的饮品,能在吃饭、喝水的同时食用,既能够满足口感,又能够增加人体抵抗力,达到延年益寿的目的,是人们非常期望的事情。
【发明内容】
【发明目的】
本发明的目的是提供一种益生菌冻干粉固体饮料,有效的防治腰酸背痛等骨质疏松症状,以及牙痛,高血压、高血脂,肠胃功能紊乱等类似于亚健康的现代病,满足现代人的生活需求。
【技术方案】
本发明的技术方案是:一种益生菌冻干粉固体饮料,含有低聚异麦芽糖、低聚果糖、低聚半乳糖、乳酸菌粉。
本发明优选的技术方案是:一种益生菌冻干粉固体饮料,含有低聚异麦芽糖1-2份,低聚果糖0.1-0.4份,低聚半乳糖0.3-0.8份,乳酸菌粉0.8-1.5份。
本发明优选的技术方案是:单位剂量的益生菌冻干粉固体饮料中,含有低聚异麦芽糖1-2g,低聚果糖0.1-0.4g,低聚半乳糖0.3-0.8g,乳酸菌粉0.8-1.5g。
本发明优选的技术方案是:单位剂量的益生菌冻干粉固体饮料中,含有低聚异麦芽糖1.5g,低聚果糖0.2g,低聚半乳糖0.5g,乳酸菌粉1.0g。
本发明技术方案中:
低聚麦芽糖,对人体内有益的双歧杆菌有强大的增殖作用,净化肠道,促进肠蠕动,防止和解除便秘及腹泻,抑制体内有害菌的繁殖和有毒腐败物质的产生。对分泌体内多种毒素的产气荚膜梭状芽胞杆菌有明显抑制作用,增强免疫力、降低胆固醇和血脂,促进老年人对钙质的吸收,是预防老年人骨质疏松的有效营养补剂,还可阻断蔗糖被变异链球菌分解,抑制蛀牙。
低聚果糖又称蔗果低聚糖,是由1~3个果糖基通过β(2—1)糖苷键与蔗糖中的果糖基结合生成的蔗果三糖、蔗果四糖和蔗果五糖等的混合物。低聚果糖可以有效的缓解便秘。
低聚半乳糖(Galactooligosaccharides,GOS)是一种具有天然属性的功能性低聚糖,可以促进有益菌生长给肠道创造健康环境,有助于营养物质的消化和吸收,避免便秘,轻松排便。
本发明所述乳酸菌粉包括乳双歧杆菌、短双岐杆菌、嗜酸乳杆菌、植物乳杆菌、干酪乳杆菌、嗜热乳杆菌。乳酸菌粉能在体内具有以下作用:一是通过繁殖产生代谢活性物质,直接为宿主提供可利用的必需氨基酸(如赖氨酸和蛋氨酸等)和各种维生素(维生素B族和K、H等),提高矿物元素的生物学活性,增强动物的营养代谢,促进生长;二是乳酸菌的生长使肠道环境呈酸性,有利于营养素的消化吸收,加强肠道的蠕动和分泌;三是乳酸菌粉能调节免疫系统、调节胃肠道正常菌群、维持微生态平衡,从而改善胃肠道功能;四是提高食物消化率和生物效价;五是降低血清胆固醇,控制体内毒素;六是抑制肠道内腐败菌生长;七是提高机体免疫力等。
本发明所述益生菌冻干粉固体饮料的制备方法,包括以下步骤:
第一步低聚异麦芽糖、低聚果糖、低聚半乳糖、乳酸菌粉分别过100目筛;
第二步称取配方量的第一步过筛的低聚异麦芽糖、低聚果糖、低聚半乳糖、乳酸菌粉,混匀;
第三步分装。
本发明所述益生菌冻干粉于0-15℃储存,温水冲服,成年人一日饮用2次。早晚饭前服用。
【有益效果】
本发明产品经过几种组分的合理配伍,在保证原有效用的前提下,产生了协同作用。经常服用本发明固体饮料,具有调节血脂,降低血液粘稠度等保护心脑血管的作用;还具缓解或防治肠胃功能紊乱等类似于亚健康的现代病,满足现代人的生活需求。
【实施例与试验例】
实施例1、低聚异麦芽糖100g,低聚果糖10g,低聚半乳糖30g,乳酸菌粉150g,按技术方案所述制备方法制备100包。
实施例2、低聚异麦芽糖200g,低聚果糖40g,低聚半乳糖80g,乳酸菌粉80g,按技术方案所述制备方法制备100包。
实施例3、低聚异麦芽糖150g,低聚果糖20g,低聚半乳糖50g,乳酸菌粉100g。,按技术方案所述制备方法制备100包,
试验例1、某科技公司,职工中不同程度的患有腹胀、腰酸背痛、便秘症状的办公及科研人员90人,随机分为3组,分别服用本发明实施例1-3的产品,每日2次,每次1包,服用第30天,所有人员的腹胀、腰酸背痛、便秘症状消失。共同感觉身体轻松愉快。
试验例2、门诊确诊血脂、血糖、血压处于临界值的人员90人,随机分为3组,分别服用本发明实施例1-3的产品,每日2次,每次1包,服用3个月后复检,血脂、血糖、血压恢复正常。
Claims (5)
1.一种益生菌冻干粉固体饮料,其特征在于,含有低聚异麦芽糖、低聚果糖、低聚半乳糖、乳酸菌粉。
2.按照权利要求1所述益生菌冻干粉固体饮料,其特征在于,含有低聚异麦芽糖1-2份,低聚果糖0.1-0.4份,低聚半乳糖0.3-0.8份,乳酸菌粉0.8-1.5份。
3.按照权利要求1所述益生菌冻干粉固体饮料,其特征在于,单位剂量的益生菌冻干粉固体饮料中,含有低聚异麦芽糖1-2g,低聚果糖0.1-0.4g,低聚半乳糖0.3-0.8g,乳酸菌粉0.8-1.5g。
4.按照权利要求1所述益生菌冻干粉固体饮料,其特征在于,单位剂量的益生菌冻干粉固体饮料中,含有低聚异麦芽糖1.5g,低聚果糖0.2g,低聚半乳糖0.5g,乳酸菌粉1.0g。
5.权利要求1所述益生菌冻干粉固体饮料的制备方法,其特征在于,包括以下步骤:
第一步低聚异麦芽糖、低聚果糖、低聚半乳糖、乳酸菌粉分别过100目筛;
第二步称取配方量的第一步过筛的低聚异麦芽糖、低聚果糖、低聚半乳糖、乳酸菌粉,混匀;
第三步分装。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711206121.1A CN107889997A (zh) | 2017-11-27 | 2017-11-27 | 一种益生菌冻干粉固体饮料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711206121.1A CN107889997A (zh) | 2017-11-27 | 2017-11-27 | 一种益生菌冻干粉固体饮料 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107889997A true CN107889997A (zh) | 2018-04-10 |
Family
ID=61806339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711206121.1A Pending CN107889997A (zh) | 2017-11-27 | 2017-11-27 | 一种益生菌冻干粉固体饮料 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107889997A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109329688A (zh) * | 2018-09-10 | 2019-02-15 | 南京医科大学 | 糖友益生菌固体饮料 |
CN110959792A (zh) * | 2018-09-30 | 2020-04-07 | 内蒙古伊利实业集团股份有限公司 | 一种含乳双歧杆菌的固体饮料及其应用 |
CN111387391A (zh) * | 2020-04-27 | 2020-07-10 | 山东亿海鹏生经贸有限公司 | 一种益生元电解质饮品的生产方法 |
CN113475664A (zh) * | 2021-07-21 | 2021-10-08 | 中盐工程技术研究院有限公司 | 一种补充天然维生素a的固体饮料 |
-
2017
- 2017-11-27 CN CN201711206121.1A patent/CN107889997A/zh active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109329688A (zh) * | 2018-09-10 | 2019-02-15 | 南京医科大学 | 糖友益生菌固体饮料 |
CN110959792A (zh) * | 2018-09-30 | 2020-04-07 | 内蒙古伊利实业集团股份有限公司 | 一种含乳双歧杆菌的固体饮料及其应用 |
CN110959792B (zh) * | 2018-09-30 | 2022-03-29 | 内蒙古伊利实业集团股份有限公司 | 一种含乳双歧杆菌的固体饮料及其应用 |
CN111387391A (zh) * | 2020-04-27 | 2020-07-10 | 山东亿海鹏生经贸有限公司 | 一种益生元电解质饮品的生产方法 |
CN113475664A (zh) * | 2021-07-21 | 2021-10-08 | 中盐工程技术研究院有限公司 | 一种补充天然维生素a的固体饮料 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104643250B (zh) | 一种可双向调节体重改善亚健康的固体饮料 | |
CN109198356A (zh) | 一种具有调节肠道功能的固体饮料及其制备方法 | |
CN105995976A (zh) | 一种具有降脂减肥作用的综合酵素粉及其应用 | |
CN113826692A (zh) | 一种益生菌固体饮料及其制备方法 | |
CN111227261A (zh) | 一种益生元组合物及其应用 | |
CN107889997A (zh) | 一种益生菌冻干粉固体饮料 | |
CN103653170A (zh) | 一种水苏糖益生菌固体饮料 | |
CN111771971A (zh) | 利于调节肠道、促进消化、改善便秘的组合物及其制备方法 | |
CN101683477A (zh) | 一种用于减肥的组合物 | |
CN105146368A (zh) | 一种改善营养不良,帮助病后术后身体康复的营养包 | |
CN102088981B (zh) | 帮助唾液分泌的唾液酸 | |
CN100553473C (zh) | 一种羊饲料添加剂 | |
CN108541953A (zh) | 一种具有调节肠道微生物结构并增殖嗜黏蛋白阿卡曼氏菌的组合物 | |
CN105249480A (zh) | 一种膳食纤维和双歧杆菌的咀嚼片及其制备方法 | |
CN105982009A (zh) | 用于调节人体肠道微生态的组合物 | |
CN102524649A (zh) | 低聚木糖果多糖片 | |
CN102613461B (zh) | 迅美减肥营养品及其制备方法 | |
CN107927788A (zh) | 一种低聚糖营养素 | |
CN104839670A (zh) | 特禀体质医学配方食品 | |
CN104146312B (zh) | 调理胃肠功能的保健品 | |
CN101347229A (zh) | 一种具有润肠通便功能的保健食品及生产方法 | |
CN104187650A (zh) | 特禀体质全营养配方食品 | |
CN104146266A (zh) | 调理黄褐斑的全营养配方食品 | |
CN105050427A (zh) | 可食用组合物以及包含其的食品、该食品的制备方法 | |
CN107136490A (zh) | 一种肽虫草保健品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180410 |
|
WD01 | Invention patent application deemed withdrawn after publication |